VEVOCTADEKIN
UNII U778Z8U9D3

Substance Identification & Data

This profile provides standardized clinical and technical data for Vevoctadekin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) U778Z8U9D3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 2768756-51-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

U778Z8U9D3

CAS Registry Number

2768756-51-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

VEVOCTADEKIN

Official standardized name for this substance within the FDA UNII nomenclature system.

NCI Thesaurus

C181677

National Cancer Institute reference terminology for clinical and research data.

INN ID

12812

Sequential identifier assigned via the WHO International Nonproprietary Name program.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Vevoctadekin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

HUMAN INTERLEUKIN 18 (IL18, INTERLEUKIN-1 GAMMA, IL-1 GAMMA, INTERFERON GAMMA-INDUCING FACTOR) FRAGMENT (1-157), ENGINEERED VARIANT (C38>S, M 51>K, K 53>S,56QP 57>LA, M 60>L, C 86>D, S105>DSUP>110DN111>SR)

INTERLEUKIN 18 (RECOMBINANT HUMAN MUTEIN CLONE ST-067)

VEVOCTADEKIN

VEVOCTADEKIN [INN]